Molecular physiology of bile acid signaling in health, disease, and aging

Cites (485)

Items 201–400 of 486

1. Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system
   Daniel P. Poole, C. Godfrey, Fiore Cattaruzza, Graeme Stuart Cottrell, Jacob G. Kirkland, Juan Carlos Pelayo, Nigel W. Bunnett, Carlos Uriel Corvera · 2010 · Neurogastroenterology & Motility
2. Molecular mechanisms underlying bile acid‐stimulated glucagon‐like peptide‐1 secretion
   H. E. Parker, K Wallis, Carel Wynand le Roux, Kai Yuen Wong, Frank M. Reimann, Fiona Mary Gribble · 2011 · British Journal of Pharmacology
3. New therapeutic concepts in bile acid transport and signaling for management of cholestasis
   Trauner, Michael, Fuchs, Claudia Daniela, Halilbasic, Emina, Paumgartner, Gustav · 2017 · Hepatology
4. The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
   Verbeke, Len, Farre, Ricard, Verbinnen, Bert, Covens, Kris, Vanuytsel, Tim, Verhaegen, Jan, Komuta, Mina, Roskams, Tania, Chatterjee, Sagnik, Annaert, Pieter et al. · 2015 · The American Journal of Pathology
5. Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
   McMahan, Rachel H., Wang, Xiaoxin X., Cheng, Lin Ling, Krisko, Tibor, Smith, Maxwell, El Kasmi, Karim, Pruzanski, Mark, Adorini, Luciano, Golden-Mason, Lucy, Levi, Moshe et al. · 2013 · Journal of Biological Chemistry
6. Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease
   Zhaoxia Yang, Wei Shen, Hang Sun · 2010 · Hepatology International
7. The Bile Acid Receptor TGR5 Activates the TRPA1 Channel to Induce Itch in Mice
   TinaMarie Lieu, Gihan Jayaweera, Peishen Zhao, Daniel P. Poole, Dane D. Jensen, Megan S. Grace, Peter McIntyre, Romke Bron, Yvette M. Wilson, Matteus Krappitz et al. · 2014 · Gastroenterology
8. FGF19 action in the brain induces insulin-independent glucose lowering
   Gregory J. Morton, Miles E. Matsen, Deanna P. Bracy, Thomas H. Meek, Nguyễn Thị Hồng, Darko Stefanovski, Richard N. Bergman, David H. Wasserman, Michael W. Schwartz · 2013 · Journal of Clinical Investigation
9. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-α and -β genes
   Jean‐François Landrier, Jyrki J. Eloranta, Stephan R. Vavricka, Gerd Achim Kullak-Ublick · 2005 · American Journal of Physiology-Gastrointestinal and Liver Physiology
10. Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
    Bo Kong, James P. Luyendyk, Ossama William Tawfik, Grace Liejun Guo · 2008 · Journal of Pharmacology and Experimental Therapeutics
11. TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice
    Anne K. McGavigan, Darline Garibay, Zachariah M. Henseler, Jack C. Chen, Ahmed Bettaieb, Fawaz G. Haj, Ruth E. Ley, Michael L. Chouinard, Bethany P. Cummings · 2015 · Gut
12. TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro
    Maria Reich, Kathleen Deutschmann, Annika Sommerfeld, Caroline Klindt, Stefanie Kluge, Ralf Kubitz, Christoph Ullmer, Wolfram Trudo Knoefel, Diran Agaid Herebian, Ertan Mayatepek et al. · 2015 · Gut
13. Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
    Sushant Bhatnagar, Holly A. Damron, F. Bradley Hillgartner · 2009 · Journal of Biological Chemistry
14. TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation.
    A. Perino, T. W. Pols, Mitsunori Nomura, S. Stein, R. Pellicciari, K. Schoonjans · 2014 · Journal of Clinical Investigation
15. A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome
    Zhao, Ling, Yang, Wei, Chen, Yang, Huang, Fengjie, Lu, Lin, Lin, Chengyuan, Huang, Tao, Ning, Ziwan, Zhai, Lixiang, Zhong, Linda L.D. et al. · 2019 · Journal of Clinical Investigation
16. An Intestinal Farnesoid X Receptor–Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice
    Cen Xie, Changtao Jiang, Jingmin Shi, Xiaoxia Gao, Dongxue Sun, Lulu Sun, Ting Wang, Shogo Takahashi, Mallappa Anitha, Kristopher W. Krausz et al. · 2016 · Diabetes
17. Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury
    Jun Pu, Ancai Yuan, Peiren Shan, Erhe Gao, Xiaoliang Wang, Yajing Wang, Wayne Bond Lau, Walter J. Koch, Xinliang Ma, Ben He · 2012 · European Heart Journal
18. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids
    Shuai Wang, Rene Martins, Megan C. Sullivan, Elliot S. Friedman, Ana M. Misic, Ayah El‐Fahmawi, Elaine Cristina Pereira De Martinis, Kevin M. O’Brien, Ying Chen, Charles W. Bradley et al. · 2019 · Microbiome
19. The Small Heterodimer Partner Interacts with the Liver X Receptor α and Represses Its Transcriptional Activity
    Carole Brendel, Kristina Schoonjans, Oronza Antonietta Botrugno, Eckardt Treuter, Johan H. Auwerx · 2002 · Molecular Endocrinology
20. Antiatherosclerotic effect of farnesoid X receptor
    Andrea Mencarelli, Barbara Renga, Eleonora Distrutti, Stefano Fiorucci · 2008 · American Journal of Physiology-Heart and Circulatory Physiology
21. Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
    Giovanni Rizzo, Daniela Passeri, Francesca Franco, Gianmario Ciaccioli, Loredana Donadio, Giorgia Rizzo, Stefano Orlandi, Bahman M. Sadeghpour, Xiaoxin X. Wang, Tao Jiang et al. · 2010 · Molecular Pharmacology
22. The Hypolipidemic Natural Product Guggulsterone Acts as an Antagonist of the Bile Acid Receptor
    Jun Wu, Chunsheng Xia, Jannika Meier, Suzhen Li, Xiao Hu, Deepak S. Lala · 2002 · Molecular Endocrinology
23. Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice
    I. Uriarte, M. G. Fernandez-Barrena, M. Monte, M. Latasa, Haisul C. Y. Chang, S. Carotti, U. Vespasiani-Gentilucci, S. Morini, Eva Vicente, A. Concepcion et al. · 2013 · Gut
24. Protective Effects of 6-Ethyl Chenodeoxycholic Acid, a Farnesoid X Receptor Ligand, in Estrogen-Induced Cholestasis
    Stefano Fiorucci, Carlo Clerici, Elisabetta Antonelli, Stefano Orlandi, Bryan J. Goodwin, Bahman M. Sadeghpour, Giuseppe Sabatino, Giuseppe Russo, Danilo Castellani, Timothy Mark Willson et al. · 2005 · Journal of Pharmacology and Experimental Therapeutics
25. A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
    Kris V. Kowdley, Raj Vuppalanchi, Cynthia Levy, Annarosa Floreani, Pietro Andreoné, Nicholas F. LaRusso, Roshan Shrestha, James F. Trotter, David Goldberg, Simon Rushbrook et al. · 2020 · Journal of Hepatology
26. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice
    Péan, Noémie, Doignon, Isabelle, Garcin, Isabelle, Besnard, Aurore, Julien, Boris, Liu, Bingkaï, Branchereau, Sophie, Spraul, Anne, Guettier, Catherine, Humbert, Lydie et al. · 2013 · Hepatology
27. Comparative Effects of Prolonged and Intermittent Stimulation of the Glucagon-Like Peptide 1 Receptor on Gastric Emptying and Glycemia
    Umapathysivam, Mahesh M., Lee, Michael Y., Jones, Karen L., Annink, Christopher E., Cousins, Caroline E., Trahair, Laurence G., Rayner, Chris K., Chapman, Marianne J., Nauck, Michael A., Horowitz, Michael et al. · 2014 · Diabetes
28. Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease
    April D. Lake, Petr Novák, Petia A. Shipkova, Nelly Aranı́bar, Donald G. Robertson, Michael D. Reily, Zhenqiang James Lu, Lois D. Lehman‐McKeeman, Nathan J. Cherrington · 2013 · Toxicology and Applied Pharmacology
29. Bile Acid Reduces the Secretion of Very Low Density Lipoprotein by Repressing Microsomal Triglyceride Transfer Protein Gene Expression Mediated by Hepatocyte Nuclear Factor-4
    Hisako Hirokane, Mayuko Nakahara, Shizuko Tachibana, Makoto Shimizu, Ryuichiro Sato · 2004 · Journal of Biological Chemistry
30. Cirrhosis and other liver disease in cystic fibrosis
    Thomas Flass, Michael R. Narkewicz · 2012 · Journal of Cystic Fibrosis
31. Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: a multicenter, randomized, double-blind, placebo-controlled phase II trial
    Hirschfield, Gideon M., Chazouillères, Olivier, Drenth, Joost P., Thorburn, Douglas, Harrison, Stephen A., Landis, Charles S., Mayo, Marlyn J., Muir, Andrew J., Trotter, James F., Leeming, Diana J. et al. · 2019 · Journal of Hepatology
32. Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress
    Irina M. Bochkis, Nir E. Rubins, Peter White, Emma Elizabeth Furth, Joshua R. Friedman, Klaus H. Kaestner · 2008 · Nature Medicine
33. Fibroblast Growth Factor-19 Action in the Brain Reduces Food Intake and Body Weight and Improves Glucose Tolerance in Male Rats
    Ryan, Karen K., Kohli, Rohit, Gutierrez-Aguilar, Ruth, Gaitonde, Shrawan G., Woods, Stephen C., Seeley, Randy J. · 2013 · Endocrinology
34. Bile acid feeding induces cholangiocyte proliferation and secretion: Evidence for bile acid–regulated ductal secretion
    Gianfranco D. Alpini, Shannon S. Glaser, Yoshiyuki Ueno, Rebecca Rodgers, Jo Lynne Phinizy, Heather Francis, Leonardo Baiocchi, Leigh A. Holcomb, Alessandra Caligiuri, Gene LeSage · 1999 · Gastroenterology
35. Methionine Restriction Extends Lifespan in Progeroid Mice and Alters Lipid and Bile Acid Metabolism
    Bárcena, Clea, Quirós, Pedro M., Durand, Sylvère, Mayoral, Pablo, Rodríguez, Francisco, Caravia, Xurde M., Mariño, Guillermo, Garabaya, Cecilia, Fernández-García, María Teresa, Kroemer, Guido et al. · 2018 · Cell Reports
36. Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
    Zhou, Mei, Wang, Xueyan, Phung, Van, Lindhout, Darrin A., Mondal, Kalyani, Hsu, Jer-Yuan, Yang, Hong, Humphrey, Mark, Ding, Xunshan, Arora, Taruna et al. · 2014 · Cancer Research
37. TGR5 potentiates GLP-1 secretion in response to anionic exchange resins
    Taoufiq Harach, Thijs W.H. Pols, Mitsunori Nomura, Adriano Maida, 光博 渡辺, Johan H. Auwerx, Kristina Schoonjans · 2012 · Scientific Reports
38. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-α/β in the adaptive response to bile acids
    Gernot Zollner, Martin Wagner, Tarek Moustafa, Peter Fickert, Dagmar Silbert, Judith Gumhold, Andrea Fuchsbichler, Emina Halilbasic, Helmut Denk, Hanns–Ulrich Marschall et al. · 2005 · American Journal of Physiology-Gastrointestinal and Liver Physiology
39. Vertical sleeve gastrectomy activates GPBAR‐1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice
    Lili Ding, Kyle M. Sousa, Lihua Jin, Bingning Dong, Byung‐Wook Kim, Ricardo Ramírez, Zhenzhou Xiao, Ying Gu, Qiaoling Yang, Jie Wang et al. · 2016 · Hepatology
40. Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study
    Trauner, Michael, Nevens, Frederik, Shiffman, Mitchell L, Drenth, Joost P H, Bowlus, Christopher L, Vargas, Victor, Andreone, Pietro, Hirschfield, Gideon M, Pencek, Richard, Malecha, Elizabeth Smoot et al. · 2019 · The Lancet Gastroenterology & Hepatology
41. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia.
    Bo Angelin, Kurt Einarsson, Kjell Hellström, Barbro Leijd · 1978 · Journal of Lipid Research
42. Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice
    Peter Fickert, Elisabeth Krones, Marion Julia Pollheimer, Andrea Thueringer, Tarek Moustafa, Dagmar Silbert, Emina Halilbasic, Min Yang, Hartmut Jaeschke, Geurt Stokman et al. · 2013 · Hepatology
43. Mechanisms of Disease: the genetic epidemiology of gallbladder stones
    Frank Lammert, Tilman Sauerbruch · 2005 · Nature Clinical Practice Gastroenterology &#38 Hepatology
44. Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice
    Elyisha A. Hanniman, Gilles C. Lambert, Tanya C. McCarthy, Christopher J. Sinal · 2005 · Journal of Lipid Research
45. FXR regulates organic solute transporters α and β in the adrenal gland, kidney, and intestine
    Hans Chulhee Lee, Yanqiao Zhang, Florence Y. Lee, Stanley F. Nelson, Frank J. Gonzalez, Peter A. Edwards · 2005 · Journal of Lipid Research
46. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis
    Mencarelli, Andrea, Renga, Barbara, Migliorati, Marco, Cipriani, Sabrina, Distrutti, Eleonora, Santucci, Luca, Fiorucci, Stefano · 2009 · The Journal of Immunology
47. Pathophysiology of Cholangiopathies
    Mario Strazzabosco, Luca Fabris, Carlo Spirlı̀ · 2005 · Journal of Clinical Gastroenterology
48. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery
    Vance L. Albaugh, Babak Banan, Joseph Antoun, Yanhua Xiong, Yan Ping Guo, Jie Ping, Muhammed Mustafa Alikhan, Blake Austin Clements, Naji N. Abumrad, Charles Robb Flynn · 2018 · Gastroenterology
49. Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice
    Xu, Yang, Li, Fei, Zalzala, Munaf, Xu, Jiesi, Gonzalez, Frank J., Adorini, Luciano, Lee, Yoon‐Kwang, Yin, Liya, Zhang, Yanqiao · 2016 · Hepatology
50. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration
    Li, Yoyo T.Y., Swales, Karen E., Thomas, Gareth J., Warner, Timothy D., Bishop-Bailey, David · 2007 · Arteriosclerosis, Thrombosis, and Vascular Biology
51. Central action of FGF19 reduces hypothalamic AGRP/NPY neuron activity and improves glucose metabolism
    Geneviève Marcelin, Young‐Hwan Jo, Xiaosong Li, Gary J. Schwartz, Ying Zhang, Nae J. Dun, Rong‐Ming Lyu, Clémence Blouet, Jaw Kang Chang, Streamson C. Chua · 2013 · Molecular Metabolism
52. FXR Deficiency Causes Reduced Atherosclerosis inLdlr−/−Mice
    Yanqiao Zhang, Xuping Wang, Charisse Vales, Florence Ying Lee, Hans Chulhee Lee, Aldons Jake Lusis, Peter A. Edwards · 2006 · Arteriosclerosis Thrombosis and Vascular Biology
53. Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases
    Suzanne Devkota, Eugene B. Chang · 2015 · Digestive Diseases
54. The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid
    Julian R.F. Walters, Ian M. Johnston, J D Nolan, Claire Vassie, Mark Pruzanski, D. A. Shapiro · 2014 · Alimentary Pharmacology & Therapeutics
55. A nontumorigenic variant of FGF19 treats cholestatic liver diseases
    Jian Luo, Brian Ko, Michael Elliott, Mei Ling Zhou, Darrin A. Lindhout, Van Phung, Carmen To, R. Marc Learned, Hui Tian, Alex M. DePaoli et al. · 2014 · Science Translational Medicine
56. Antibiotic effects on gut microbiota and metabolism are host dependent
    Shiho Fujisaka, Siegfried Ussar, Clary B. Clish, Suzanne Devkota, Jonathan M. Dreyfuss, Masaji Sakaguchi, Marion Soto, Masahiro Konishi, Samir Softic, Emrah Altındiş et al. · 2016 · Journal of Clinical Investigation
57. Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)
    Brenton Flatt, Richard Martin, Tielin Wang, Paige E. Mahaney, Brett Murphy, Xiao‐Hui Gu, Paul Foster, Jiali Li, Parinaz C. Pircher, Mary L. Petrowski et al. · 2009 · Journal of Medicinal Chemistry
58. Bile acids induce monocyte differentiation toward interleukin‐12 hypo‐producing dendritic cells via a TGR5‐dependent pathway
    Riko Ichikawa, Tetsuro Takayama, Kazuaki Yoneno∥, Nobuhiko Kamada, Mina T. Kitazume, Hajime Higuchi, Katsuyoshi Matsuoka, 光博 渡辺, Hiroshi Itoh, Takanori Kanai∥ et al. · 2012 · Immunology
59. On the Regulation of‘ Bile Acid Formation in the Rat Liver
    S. Bergström, Henry Danielsson · 1958 · Acta Physiologica Scandinavica
60. Bile Acids Acutely Stimulate Insulin Secretion of Mouse β-Cells via Farnesoid X Receptor Activation and KATP Channel Inhibition
    Martina Düfer, Katrin Hörth, Rebecca Wagner, Björn Schittenhelm, Susanne Prowald, Thomas F.J. Wagner, Johannes Oberwinkler, Robert Łukowski, Frank J. Gonzalez, Peter Krippeit‐Drews et al. · 2012 · Diabetes
61. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol
    F Grünhage, Monica Acalovschi, Simona Tirziu, Maja Walier, Thomas F. Wienker, Anca Ciocan, Ofelia Moșteanu, Tilman Sauerbruch, Frank Lammert · 2007 · Hepatology
62. Bile acids activate EGF receptor via a TGF-α-dependent mechanism in human cholangiocyte cell lines
    Nathan W. Werneburg, Jung‐Hwan Yoon, Hajime Higuchi, Gregory James Gores · 2003 · American Journal of Physiology-Gastrointestinal and Liver Physiology
63. Dose-Response of Five Bile Acids on Serum and Liver Bile Acid Concentrations and Hepatotoxicty in Mice
    Peizhen Song, Youcai Zhang, Curtis D. Klaassen · 2011 · Toxicological Sciences
64. Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR−/− and apoE−/− mice
    Helen B. Hartman, Stephen J. Gardell, Chris J. Petucci, Shuguang Wang, Julie A. Krueger, Mark J. Evans · 2009 · Journal of Lipid Research
65. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice
    Matthew J. Potthoff, Austin Potts, TianTeng He, João André Gonçalves Duarte, Ronald Taussig, David J. Mangelsdorf, Steven A. Kliewer, Shawn C. Burgess · 2012 · American Journal of Physiology-Gastrointestinal and Liver Physiology
66. Chronic cholestatic diseases
    Raoul Y. Poupon, Olivier Chazouillères, Renée E. Poupon · 2000 · Journal of Hepatology
67. Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice
    Zhou, Mei, Learned, R. Marc, Rossi, Stephen J., DePaoli, Alex M., Tian, Hui, Ling, Lei · 2017 · Hepatology Communications
68. Farnesoid X Receptor Inhibits the Transcriptional Activity of Carbohydrate Response Element Binding Protein in Human Hepatocytes
    Sandrine Caron, Carolina Huaman Samanez, Hélène Dehondt, Maheul Ploton, Olivier Briand, Fleur Lien, Emilie Dorchies, Julie Dumont, Catherine Postic, Bertrand Cariou et al. · 2013 · Molecular and Cellular Biology
69. Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk
    Fleur Lien, Alexandre Berthier, Emmanuel Bouchaert, Céline Gheeraert, Jérémy Alexandre, Geoffrey Porez, Janne Prawitt, Hélène Dehondt, Maheul Ploton, Sophie Colin et al. · 2014 · Journal of Clinical Investigation
70. Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice
    Zhang, Lisheng, Wang, Yan-Dong, Chen, Wei-Dong, Wang, Xichun, Lou, Guiyu, Liu, Nian, Lin, Min, Forman, Barry M., Huang, Wendong · 2012 · Hepatology
71. FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid
    Friedman, Elliot S., Li, Yun, Shen, Ting-Chin David, Jiang, Jack, Chau, Lillian, Adorini, Luciano, Babakhani, Farah, Edwards, Jeffrey, Shapiro, David, Zhao, Chunyu et al. · 2018 · Gastroenterology
72. G‐protein‐coupled bile acid receptor plays a key role in bile acid metabolism and fasting‐induced hepatic steatosis in mice
    Ajay Chowdary Donepudi, Shannon Boehme, Feng Li, John Y.L. Chiang · 2016 · Hepatology
73. Hepatic glucose sensing is required to preserve β cell glucose competence
    Pascal Seyer, David Vallois, Carole Poitry‐Yamate, Frédéric Schütz, Salima Metref, David Tarussio, Pierre Maechler, Bart Staels, Bernard Lanz, Rolf Gruetter A et al. · 2013 · Journal of Clinical Investigation
74. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass
    Simonen, M., Dali-Youcef, N., Kaminska, D., Venesmaa, S., Käkelä, P., Pääkkönen, M., Hallikainen, M., Kolehmainen, M., Uusitupa, M., Moilanen, L. et al. · 2012 · Obesity Surgery
75. Bile Acid-Induced Arrhythmia Is Mediated by Muscarinic M2 Receptors in Neonatal Rat Cardiomyocytes
    Siti Hamimah Sheikh Abdul Kadir, Michele Miragoli, Shadi Abu‐Hayyeh, Alexey V. Moshkov, Qilian Xie, Verena Keitel, Viacheslav O. Nikolaev, Catherine Williamson, Julia Gorelik · 2010 · PLoS ONE
76. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis
    Divya P. Kumar, Amon Asgharpour, Faridoddin Mirshahi, So Hyun Park, Sichen Liu, Yumi Imai, Jerry L. Nadler, John R. Grider, Karnam S. Murthy, Arun Jayant Sanyal · 2016 · Journal of Biological Chemistry
77. Transintestinal Cholesterol Transport Is Active in Mice and Humans and Controls Ezetimibe-Induced Fecal Neutral Sterol Excretion
    Lily Jakulj, Theo H. van Dijk, Jan Freark de Boer, Ruud S. Kootte, Marleen Schonewille, Yared Paalvast, Theo S Boer, Vincent W. Bloks, Renze Boverhof, Max Nieuwdorp et al. · 2016 · Cell Metabolism
78. The Genetics of Complex Cholestatic Disorders
    Gideon Morris Hirschfield, Roger William Chapman, Tom H. Karlsen, Frank Lammert, Konstantinos N. Lazaridis, Andrew L. Mason · 2013 · Gastroenterology
79. Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice
    Jan Freark de Boer, Marleen Schonewille, Marije Boesjes, Henk Wolters, Vincent W. Bloks, Trijnie Bos, Theo H. van Dijk, Angelika Jurdzinski, Renze Boverhof, Justina Clarinda Wolters et al. · 2017 · Gastroenterology
80. Comparative Efficacy and Side Effects of Ursodeoxycholic and Chenodeoxycholic Acids in Dissolving Gallstones
    Hans Fromm, James W. Roat, Víctor H. González, Rajendra P. Sarva, Sirus Farivar · 1983 · Gastroenterology
81. TGR5 and Immunometabolism: Insights from Physiology and Pharmacology.
    A. Perino, K. Schoonjans · 2015 · TIPS - Trends in Pharmacological Sciences
82. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal
    Johannes Schmitt, Bo Kong, Bruno Stieger, Oliver Tschopp, Simon M. Schultze, Monika Rau, Achim Weber, Beat Müllhaupt, Grace Liejun Guo, Andreas Geier · 2014 · Liver International
83. Nuclear receptors in human immune cells: Expression and correlations
    Andrea B. Schote, Jonathan D. Turner, Jang Schiltz, Claude P. Muller · 2006 · Molecular Immunology
84. Bile Acid-Activated Receptors: A Review on FXR and Other Nuclear Receptors
    Dong‐Ju Shin, Li Wang · 2019 · Handbook of experimental pharmacology
85. Effect of type and amount of dietary fat and 1,2-dimethylhydrazine on biliary bile acids, fecal bile acids, and neutral sterols in rats.
    Bandaru S. Reddy, Surinder Mangat, Aron Sheinfil, John H. Weisburger, Ernst L. Wynder · 1977 · PubMed
86. Bile acids: short and long term effects in the intestine
    Antal Bajor, Per‐Göran Gillberg, Hasse Abrahamsson · 2010 · Scandinavian Journal of Gastroenterology
87. FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice
    Henning Wittenburg, Malcolm A. Lyons, Renhua Li, Gary A. Churchill, Martin C. Carey, Beverly J. Paigen · 2003 · Gastroenterology
88. Nuclear Receptors HNF4α and LRH-1 Cooperate in Regulating Cyp7a1 in Vivo
    Serkan Kır, Yuan Zhang, Robert D. Gerard, Steven A. Kliewer, David J. Mangelsdorf · 2012 · Journal of Biological Chemistry
89. Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
    Mohammad Shadab Siddiqui, Mark L. Van Natta, Margery A. Connelly, Raj Vuppalanchi, Brent A. Neuschwander‐Tetri, James Tonascia, Cynthia D. Guy, Rohit Seth Loomba, Srinivasan Dasarathy, Julia J. Wattacheril et al. · 2019 · Journal of Hepatology
90. Heart and bile acids – Clinical consequences of altered bile acid metabolism
    Tharni Vasavan, Elisa Ferraro, Effendi Ibrahim, Peter H. Dixon, Julia Gorelik, Catherine Williamson · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
91. Alterations in xenobiotic metabolism in the long‐lived Little mice
    Amador‐Noguez, Daniel, Dean, Adam, Huang, Wendong, Setchell, Kenneth, Moore, David, Darlington, Gretchen · 2007 · Aging Cell
92. Cholestasis: human disease and experimental animal models
    Emilio A. Rodríguez-Garay · 2003 · Annals of Hepatology
93. Gene expression profile of long‐lived Ames dwarf mice and Little mice
    Amador‐Noguez, Daniel, Yagi, Kazuo, Venable, Susan, Darlington, Gretchen · 2004 · Aging Cell
94. Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor
    Thijs W.H. Pols, Teresa Puchner, H. Inci Korkmaz, Mariska Vos, Maarten R. Soeters, Carlie J.M. de Vries · 2017 · PLoS ONE
95. Effects of FXR in foam-cell formation and atherosclerosis development
    Grace Liejun Guo, Silvia Santamarina-Fojo, Taro E. Akiyama, Marcelo J. Amar, Beverly J. Paigen, Bryan Brewer, Frank J. Gonzalez · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
96. Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATPchannels
    Brigitte A. Lavoie, Onesmo B. Balemba, Cody B. Godfrey, Conall A. Watson, Galya Vassileva, Carlos Uriel Corvera, Mark T. Nelson, Gary M. Mawe · 2010 · The Journal of Physiology
97. The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes
    Keitel, Verena, Ullmer, Christoph, Häussinger, Dieter · 2010 · Biological Chemistry
98. Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis
    Johannes R. Hov, Verena Keitel, Jon K. Laerdahl, Lina Spomer, Eva Ellinghaus, Abdou ElSharawy, Espen Melum, Kirsten Muri Boberg, Thomas Manke, Tobias C. Balschun et al. · 2010 · PLoS ONE
99. SIRT1 Controls Liver Regeneration by Regulating Bile Acid Metabolism Through Farnesoid X Receptor and Mammalian Target of Rapamycin Signaling
    Juan L. García‐Rodríguez, Lucía Barbier‐Torres, Sara Fernández-Álvarez, Virginia Gutiérrez‐de Juan, María Jesús Monte, Emina Halilbasic, Daniel Herranz, Luis Álvarez, Patricia Aspichueta, José J.G. Marı́n et al. · 2013 · Hepatology
100. Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2‐deficient mice
     Mei Zhou, R. Marc Learned, Stephen J. Rossi, Alex M. DePaoli, Hui Tian, Lei Ling · 2015 · Hepatology
101. Loss of FXR Protects against Diet-Induced Obesity and Accelerates Liver Carcinogenesis in ob/ob Mice
     Yanqiao Zhang, Xuemei Ge, Lydia A. Heemstra, Weidong Chen, Jiesi Xu, Joseph L. Smith, Huiyan Ma, Neda Kasim, Peter A. Edwards, Colleen M. Novak · 2012 · Molecular Endocrinology
102. Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids
     Vance L. Albaugh, Charles Robb Flynn, Steven B. Cai, Yi Xiao, Robyn A. Tamboli, Naji N. Abumrad · 2015 · The Journal of Clinical Endocrinology & Metabolism
103. A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity
     Kim, Dong‐Hyun, Xiao, Zhen, Kwon, Sanghoon, Sun, Xiaoxiao, Ryerson, Daniel, Tkac, David, Ma, Ping, Wu, Shwu‐Yuan, Chiang, Cheng‐Ming, Zhou, Edward et al. · 2015 · The EMBO Journal
104. Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin–proteasomal degradation
     Ji Miao, Zhen Xiao, Deepthi Kanamaluru, Gyesik Min, Peter M. Yau, Timothy D. Veenstra, Ewa C. S. Ellis, Steve Strom, Kelly M. Suino-Powell, H. Eric Xu et al. · 2009 · Genes & Development
105. REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis
     Vlad Ratziu, Arun Jayant Sanyal, Rohit Seth Loomba, Mary Eugenia Rinella, Stephen A. Harrison, Quentin Mark Anstee, Zachary D Goodman, Pierre Bédossa, Leigh MacConell, Reshma Shringarpure et al. · 2019 · Contemporary Clinical Trials
106. Dual Activation of the Bile Acid Nuclear Receptor FXR and G-Protein-Coupled Receptor TGR5 Protects Mice against Atherosclerosis
     Shinobu Miyazaki‐Anzai, Masashi Masuda, Moshe Levi, Audrey L. Keenan, Makoto Miyazaki · 2014 · PLoS ONE
107. NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial
     Mayo, Marlyn J., Wigg, Alan J., Leggett, Barbara A., Arnold, Hays, Thompson, Alexander J., Weltman, Martin, Carey, Elizabeth J., Muir, Andrew J., Ling, Lei, Rossi, Stephen J. et al. · 2018 · Hepatology Communications
108. Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
     Zhou, Mei, Yang, Hong, Learned, R. Marc, Tian, Hui, Ling, Lei · 2017 · Nature Communications
109. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation
     Degirolamo, Chiara, Modica, Salvatore, Vacca, Michele, Di Tullio, Giuseppe, Morgano, Annalisa, D'Orazio, Andria, Kannisto, Kristina, Parini, Paolo, Moschetta, Antonio · 2015 · Hepatology
110. Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
     Kavita S. Jadhav, Yang Xu, Yanyong Xu, Yuanyuan Li, Jiesi Xu, Yingdong Zhu, Luciano Adorini, Yoon‐Kwang Lee, Takhar Kasumov, Liya Yin et al. · 2018 · Molecular Metabolism
111. Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease
     Nijmeijer, Rian M., Gadaleta, Raffaella M., van Mil, Saskia W. C., van Bodegraven, Adriaan A., Crusius, J. Bart A., Dijkstra, Gerard, Hommes, Daan W., de Jong, Dirk J., Stokkers, Pieter C. F., Verspaget, Hein W. et al. · 2011 · PLoS ONE
112. Virus-induced accumulation of intracellular bile acids activates the TGR5-β-arrestin-SRC axis to enable innate antiviral immunity
     Ming‐Ming Hu, Wen-Rui He, Peng Gao, Qing Yang, Ke Feng He, Li-Bo Cao, Shu Li, Yu‐Qi Feng, Hong‐Bing Shu · 2019 · Cell Research
113. Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives
     Emmanuel Somm, François R. Jornayvaz · 2018 · Endocrine Reviews
114. Chemical genetic screen identifies lithocholic acid as an anti-aging compound that extends yeast chronological life span in a TOR-independent manner, by modulating housekeeping longevity assurance processes
     Alexander A. Goldberg, Vincent R. Richard, Pavlo Kyryakov, Simon D. Bourque, Adam Beach, Michelle T. Burstein, Anastasia Glebov, Olivia Koupaki, Tatiana Boukh‐Viner, Christopher Gregg et al. · 2010 · Aging
115. Farnesoid X Receptor Alleviates Age-Related Proliferation Defects in Regenerating Mouse Livers by Activating Forkhead Box M1b Transcription
     Chen, Wei-Dong, Wang, Yan-Dong, Zhang, Lisheng, Shiah, Steven, Wang, Meihua, Yang, Fan, Yu, Donna, Forman, Barry M., Huang, Wendong · 2010 · Hepatology
116. Positive regulation of osteogenesis by bile acid through FXR
     Sun Wook Cho, Jee Hyun An, Hyojung Park, Jae‐Yeon Yang, Hyung Jin Choi, Sang Wan Kim, Young Joo Park, Seong Yeon Kim, Mijung Yim, Wook‐Young Baek et al. · 2013 · Journal of Bone and Mineral Research
117. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids
     Justine H. Zhang, Jonathan Nolan, Sarah L. Kennie, Ian M. Johnston, Tracy K. Dew, Peter H. Dixon, Catherine Williamson, Julian R.F. Walters · 2013 · American Journal of Physiology-Gastrointestinal and Liver Physiology
118. Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes
     Cédric Langhi, Cédric Le May, Sanae Kourimate, Sandrine Caron, Bart Staels, Michel Krempf, Philippe Costet, Bertrand Cariou · 2008 · FEBS Letters
119. Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia
     Zhang, Yanqiao, Yin, Liya, Anderson, Jody, Ma, Huiyan, Gonzalez, Frank J., Willson, Timothy M., Edwards, Peter A. · 2010 · Journal of Biological Chemistry
120. Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure
     光博 渡辺, Kohkichi Morimoto, Sander M. Houten, Nao Kaneko-Iwasaki, Taichi Sugizaki, Yasushi Horai, Chikage Mataki, Hiroyuki Sato, Karin Murahashi, Eri Arita et al. · 2012 · PLoS ONE
121. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome
     Łukasz Kaska, Tomasz Śledziński, Agnieszka Chomiczewska, Agnieszka Dettlaff‐Pokora, Julian Świerczyński · 2016 · World Journal of Gastroenterology
122. Divergent effects of resistance and endurance exercise on plasma bile acids, FGF19, and FGF21 in humans
     Thomas Hoffmann Morville, Ronni Eg Sahl, Samuel A.J. Trammell, Jens Skjoldan Svenningsen, Matthew Paul Gillum, Jørn Wulff Helge, Christoffer Clemmensen · 2018 · JCI Insight
123. Resistance of SHP-null Mice to Bile Acid-induced Liver Damage
     Li Wang, Yunqing Han, Changsoo Kim, Yoon‐Kwang Lee, David D. Moore · 2003 · Journal of Biological Chemistry
124. Novel Mechanistic Insights into Ectodomain Shedding of EGFR Ligands Amphiregulin and TGF-α: Impact on Gastrointestinal Cancers Driven by Secondary Bile Acids
     Nagaraj S. Nagathihalli, Yugandhar Beesetty, Wooin Lee, Mary Kay Washington, Xi Chen, Albert Craig Lockhart, Nipun B. Merchant · 2014 · Cancer Research
125. A Steroid Receptor–MicroRNA Switch Regulates Life Span in Response to Signals from the Gonad
     Yidong Shen, Joshua Wollam, Daniel B. Magner, Oezlem Karalay, Adam Antebi · 2012 · Science
126. Regulation of the mouse organic solute transporter α-β, Ostα-Ostβ, by bile acids
     Tamara Frankenberg, Anuradha Rao, Frank Chen, Jamie Haywood, Benjamin L. Shneider, Paul A. Dawson · 2005 · American Journal of Physiology-Gastrointestinal and Liver Physiology
127. Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis
     D. CHIANELLI, Paul V. Rucker, Jason T. Roland, David C. Tully, John T. Nelson, Xiaodong Liu, Badry D. Bursulaya, Eloy D. Hernandez, Jane Wu, Mahavir Prashad et al. · 2020 · Journal of Medicinal Chemistry
128. Fibroblast growth factor 15 deficiency impairs liver regeneration in mice.
     B. Kong, J. Huang, Yan Zhu, Guodong Li, Jessica A. Williams, Steven Shen, L. Aleksunes, J. Richardson, U. Apte, David A. Rudnick et al. · 2014 · American Journal of Physiology - Gastrointestinal and Liver Physiology
129. Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice
     Kim, Kang Ho, Choi, Sungwoo, Zhou, Ying, Kim, Eun Young, Lee, Jae Man, Saha, Pradip K., Anakk, Sayeepriyadarshini, Moore, David D. · 2017 · Hepatology
130. Role of TGR5 (GPBAR1) in Liver Disease
     Häussinger, Dieter, Keitel, Verena · 2018 · Seminars in Liver Disease
131. Comparative Metabolomics Reveals Endogenous Ligands of DAF-12, a Nuclear Hormone Receptor, Regulating C. elegans Development and Lifespan
     Parag Mahanti, Neelanjan Bose, Axel Bethke, Joshua C. Judkins, Joshua Wollam, Kathleen J. Dumas, Anna M. Zimmerman, Sydney L. Campbell, Patrick J Hu, Adam Antebi et al. · 2014 · Cell Metabolism
132. The exercise-inducible bile acid receptor Tgr5 improves skeletal muscle function in mice
     Takashi Sasaki, Ayane Kuboyama, Moeko Mita, Shotaro Murata, Makoto Shimizu, Jun Inoue, Kazutoshi Mori, Ryuichiro Sato · 2018 · Journal of Biological Chemistry
133. Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis
     Christopher L. Bowlus, Paul J. Pockros, Andreas Emanuel Kremer, Albert Rodrigo Parés, Lisa Forman, Joost P.H. Drenth, Stephen D. Ryder, Luigi Terracciano, Yuying Jin, Alexander Liberman et al. · 2019 · Clinical Gastroenterology and Hepatology
134. The nuclear receptor FXR is expressed in pancreatic β‐cells and protects human islets from lipotoxicity
     Iuliana Ristea Popescu, Audrey Helleboid‐Chapman, Anthony Lucas, Brigitte Vandewalle, Julie Dumont, Emmanuel Bouchaert, Bruno Derudas, Julie A. Kerr-Conte, Sandrine Caron, François N. Pattou et al. · 2010 · FEBS Letters
135. Targeting FXR in Cholestasis
     Verena Keitel, Carola Dröge, Dieter Häussinger · 2019 · Handbook of experimental pharmacology
136. Independent Repression of Bile Acid Synthesis and Activation of c-Jun N-terminal Kinase (JNK) by Activated Hepatocyte Fibroblast Growth Factor Receptor 4 (FGFR4) and Bile Acids
     Chundong Yu, Fen Wang, Chengliu Jin, Xinqiang Huang, Wallace L. McKeehan · 2005 · Journal of Biological Chemistry
137. Antibacterial activity of bile salts against common biliary pathogens
     Joseph J.�Y. Sung, Eldon A. Shaffer, J. W. Costerton · 1993 · Digestive Diseases and Sciences
138. Bile acids induce arrhythmias in human atrial myocardium—implications for altered serum bile acid composition in patients with atrial fibrillation
     Peter P. Rainer, Uwe Primeßnig, Sandra Harenkamp, Bernhard Doleschal, Markus Wallner, Guenter Fauler, Tatjana Stojaković, Rolf Wachter, Ameli Yates, Klaus Groschner et al. · 2013 · Heart
139. Hypertrophic Cardiomyopathy and Dysregulation of Cardiac Energetics in A Mouse Model of Biliary Fibrosis
     Moreshwar S. Desai, Zainuer Shabier, Michael D. Taylor, Fong Wilson Lam, Sundararajah Thevananther, Astrid Kosters, Saul J. Karpen · 2010 · Hepatology
140. Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice
     Yan Lu, Zhimin Ma, Zhijian Zhang, Xuelian Xiong, Xiaolin Wang, Huijie Zhang, Guojun Shi, Xuefeng Xia, Guang Ning, Xiaoying Li · 2013 · Gut
141. Age-Related Changes of Plasma Bile Acid Concentrations in Healthy Adults—Results from the Cross-Sectional KarMeN Study
     Lara Frommherz, Achim Bub, Eva Hummel, Manuela J. Rist, Alexander Röth, Bernhard Watzl, Sabine Emma Kulling · 2016 · PLoS ONE
142. Reduction in hepatic secondary bile acids caused by short-term antibiotic-induced dysbiosis decreases mouse serum glucose and triglyceride levels
     Takuya Kuno, Mio Hirayama‐Kurogi, Shingo Ito, Sumio Ohtsuki · 2018 · Scientific Reports
143. Synthetic Farnesoid X Receptor Agonists Induce High-Density Lipoprotein-Mediated Transhepatic Cholesterol Efflux in Mice and Monkeys and Prevent Atherosclerosis in Cholesteryl Ester Transfer Protein Transgenic Low-Density Lipoprotein Receptor (−/−) Mice
     Eva Hambruch, Shinobu Miyazaki‐Anzai, Ulrike K. Hahn, Silke Matysik, Alfred Boettcher, Sanja Perović‐Ottstadt, Thomas Schlüter, Olaf D. Kinzel, Helen Desiree Krol, Ulrich Deuschle et al. · 2012 · Journal of Pharmacology and Experimental Therapeutics
144. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice
     Susagna Padrissa‐Altés, Marc Bachofner, Roman L. Bogorad, Lea Maria Pohlmeier, Thomas Rossolini, Friederike Böhm, Gerhard Liebisch, Claus Hellerbrand, Victor Koteliansky, Tobias Speicher et al. · 2014 · Gut
145. Dual targeting of bile acid receptor-1 (TGR5) and farnesoid X receptor (FXR) prevents estrogen-dependent bone loss in mice
     Li, Zhenxi, Huang, Jinping, Wang, Fanhua, Li, Wenjun, Wu, Xian, Zhao, Chenglong, Zhao, Jian, Wei, Haifeng, Wu, Zhipeng, Qian, Ming et al. · 2019 · Journal of Bone and Mineral Research
146. Importance of Large Intestine in Regulating Bile Acids and Glucagon-Like Peptide-1 in Germ-Free Mice
     Felcy Pavithra Selwyn, Iván L. Csanaky, Youcai Zhang, Curtis D. Klaassen · 2015 · Drug Metabolism and Disposition
147. Fecal neutral steroids and bile acids from germfree rats
     Thomas F. Kellogg, Bernard S. Wostmann · 1969 · Journal of Lipid Research
148. G-Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5) Agonists Reduce the Production of Proinflammatory Cytokines and Stabilize the Alternative Macrophage Phenotype
     Klemens Hoegenauer, Luca Arista, Niko Schmiedeberg, Gudrun Werner, Herbert Jaksche, Rochdi Bouhelal, Deborah G. Nguyen, B. Ganesh Bhat, Layla Raad, Céline Rauld et al. · 2014 · Journal of Medicinal Chemistry
149. The Farnesoid X Receptor Regulates Adipocyte Differentiation and Function by Promoting Peroxisome Proliferator-activated Receptor-γ and Interfering with the Wnt/β-Catenin Pathways
     Mouaadh Abdelkarim, Sandrine Caron, Christian Duhem, Janne Prawitt, Julie Dumont, Anthony Lucas, Emmanuel Bouchaert, Olivier Briand, John Brozek, Folkert Kuipers et al. · 2010 · Journal of Biological Chemistry
150. Molecular Control of Systemic Bile Acid Homeostasis by the Liver Glucocorticoid Receptor
     Adam J. Rose, Mauricio Berriel Díaz, Anja Reimann, Johanna Klement, Tessa Walcher, Anja Krones, Oliver Strobel, Jens Martin Werner, Achim Peters, Anna Kleyman et al. · 2011 · Cell Metabolism
151. Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid
     Noortje Ijssennagger, Aafke W. F. Janssen, Alexandra Milona, José M. Ramos Pittol, Danielle A.A. Hollman, Michal Mokrý, Bark Betzel, Frits J. Berends, Ignace M. C. Janssen, Saskia W. C. van Mil et al. · 2016 · Journal of Hepatology
152. Lithocholic acid down-regulation of NF-κB activity through vitamin D receptor in colonic cancer cells
     Jun Sun, Reba Mustafi, Sonia Cerda, Anusara Chumsangsri, Yinglin Xia, Yan Chun Li, Marc Bissonnette · 2008 · The Journal of Steroid Biochemistry and Molecular Biology
153. Cytoplasmic Tyrosine Phosphatase Shp2 Coordinates Hepatic Regulation of Bile Acid and FGF15/19 Signaling to Repress Bile Acid Synthesis
     Shuangwei Li, Diane DiFang Hsu, Bing Li, Xiaolin Luo, Nazilla B. Alderson, Liping Qiao, Lina Ma, Helen He Zhu, Zhao He, Kelly M. Suino-Powell et al. · 2014 · Cell Metabolism
154. The Bile Acid Receptor TGR5 Does Not Interact with β-Arrestins or Traffic to Endosomes but Transmits Sustained Signals from Plasma Membrane Rafts
     Dane D. Jensen, Cody B. Godfrey, Christian Niklas, Meritxell Canals, Martina Kočan, Daniel P. Poole, Jane E. Murphy, Farzad Alemi, Graeme Stuart Cottrell, Christoph Korbmacher et al. · 2013 · Journal of Biological Chemistry
155. FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade
     Hai Li, Chen Frank, Quan Shang, Luxing Pan, Benjamin L. Shneider, John Y.L. Chiang, BARRY MARC FORMAN, Meenakshisundaram Ananthanarayanan, G. Stephen Tint, Gerald Salen et al. · 2004 · American Journal of Physiology-Gastrointestinal and Liver Physiology
156. The normal mechanisms of pregnancy-induced liver growth are not maintained in mice lacking the bile acid sensor Fxr.
     A. Milona, B. Owen, S. V. van Mil, D. Dormann, C. Mataki, M. Boudjelal, W. Cairns, K. Schoonjans, S. Milligan, M. Parker et al. · 2010 · American Journal of Physiology - Gastrointestinal and Liver Physiology
157. Reprogramming of pro-inflammatory human macrophages to an anti-inflammatory phenotype by bile acids
     M. Wammers, Anna-Kathrin Schupp, J. Bode, C. Ehlting, S. Wolf, R. Deenen, K. Köhrer, D. Häussinger, D. Graf · 2018 · Scientific Reports
158. Cl- secretion induced by bile salts. A study of the mechanism of action based on a cultured colonic epithelial cell line.
     Kiertisin Dharmsathaphorn, P. A. Huott, Piyapong Vongkovit, Gregory Beuerlein, Stephen Jacob Pandol, Helmut V. Ammon · 1989 · Journal of Clinical Investigation
159. Splenic dendritic cell involvement in FXR-mediated amelioration of DSS colitis
     Vittoria Massafra, Noortje Ijssennagger, Maud Plantinga, Alexandra Milona, José M. Ramos Pittol, Marianne L. Boes, Saskia W. C. van Mil · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
160. Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice†
     Simrat P. S. Saini, Ying Mu, Haibiao Gong, David Toma, Hirdesh Uppal, Songrong Ren, Song Li, Samuel Mark Poloyac, Wen Xie · 2005 · Hepatology
161. A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo
     Nuruddeen D. Lewis, Lori A. Patnaude, Josephine Pelletier, Donald J. Souza, Susan Lukas, Jim King, Jonathan D. Hill, Dimitria E. Stefanopoulos, Kelli R. Ryan, Sudha N. Desai et al. · 2014 · PLoS ONE
162. The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids
     Ducastel, Sarah, Touche, Véronique, Trabelsi, Mohamed-Sami, Boulinguiez, Alexis, Butruille, Laura, Nawrot, Margaux, Peschard, Simon, Chávez-Talavera, Oscar, Dorchies, Emilie, Vallez, Emmanuelle et al. · 2020 · Scientific Reports
163. Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis
     Peggy Pui-Kay Ho, Lawrence Steinman · 2016 · Proceedings of the National Academy of Sciences
164. Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes
     Gerardo Calderón, ALISON N. MCRAE, Juraj Rievaj, Judith A. Davis, Inuk Zandvakili, Sara Linker Nord, Duane B. Burton, Geoffrey P. Roberts, Frank M. Reimann, Bronislava R. Gedulin et al. · 2020 · EBioMedicine
165. Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway
     Senthilkumar Rajagopal, Divya P. Kumar, Sunila Mahavadi, Sayak Bhattacharya, Ruizhe Zhou, Carlos Uriel Corvera, Nigel W. Bunnett, John R. Grider, Karnam S. Murthy · 2012 · American Journal of Physiology-Gastrointestinal and Liver Physiology
166. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice
     Vittoria Massafra, Alexandra Milona, Harmjan R. Vos, Ruben J. Jesus Faustino Ramos, Johan Gerrits, Ellen C.L. Willemsen, José M. Ramos Pittol, Noortje Ijssennagger, Martin Houweling, Hubertus C.M.T. Prinsen et al. · 2017 · Gastroenterology
167. Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice
     Patricia D. Finn, David J. Rodriguez, Jill N. Kohler, Zhengfeng Jiang, Sindy Wan, Erick J. Blanco, Andrew J. King, Tao Chen, Noah Bell, Dean R. Dragoli et al. · 2019 · American Journal of Physiology-Gastrointestinal and Liver Physiology
168. Transient impairment of the adaptive response to fasting in FXR‐deficient mice
     Bertrand Cariou, Kirsten van Harmelen, Daniel Durán-Sandoval, Theo H. van Dijk, Aldo Grefhorst, Emmanuel Bouchaert, Jean‐Charles Fruchart, Frank J. Gonzalez, Folkert Kuipers, Bart Staels · 2005 · FEBS Letters
169. Liver Injury in Patients With Cholestatic Liver Disease Treated With Obeticholic Acid
     John E. Eaton, Raj Vuppalanchi, K. Rajender Reddy, Sanjaya Kumar Satapathy, Bilal Ali, Patrick S. Kamath · 2019 · Hepatology
170. L-Cell Differentiation Is Induced by Bile Acids Through GPBAR1 and Paracrine GLP-1 and Serotonin Signaling
     Mari Lilith Lund, Giovanni Sorrentino, Kristoffer Lihme Egerod, Chantal Kroone, Brynjulf Mortensen, Filip Krag Knop, Frank M. Reimann, Fiona Mary Gribble, Daniel J. Drucker, Eelco J.P. de Koning et al. · 2020 · Diabetes
171. The Methyl Transferase PRMT1 Functions as Co-Activator of Farnesoid X Receptor (FXR)/9-cis Retinoid X Receptor and Regulates Transcription of FXR Responsive Genes
     Giovanni Rizzo, Barbara Renga, Elisabetta Antonelli, Daniela Passeri, Roberto Pellicciari, Stefano Fiorucci · 2005 · Molecular Pharmacology
172. Bile acids and their respective conjugates elicit different responses in neonatal cardiomyocytes: role of Gi protein, muscarinic receptors and TGR5
     Effendi Ibrahim, Ivan A. Diakonov, Dulasi Arunthavarajah, Teresa Swift, Mary Goodwin-Trotman, Saraid McIlvride, Vanya Nikolova, Catherine Williamson, Julia Gorelik · 2018 · Scientific Reports
173. Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice
     Daniel A. Briere, Xiaoping Ruan, Christine Cheng, Angela M. Siesky, Thomas E. Fitch, Carmen Dominguez, Sonia Gutiérrez Sanfeliciano, Carlos Montero, Chen S. Suen, Yanping Xu et al. · 2015 · PLoS ONE
174. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation
     Jun Yao · 2014 · World Journal of Gastroenterology
175. Administration of antibiotics contributes to cholestasis in pediatric patients with intestinal failure via the alteration of FXR signaling
     Yongtao Xiao, Kejun Zhou, Ying Lu, Weihui Yan, Wei Cai, Ying Wang · 2018 · Experimental & Molecular Medicine
176. Fibroblast Growth Factor 19 Treatment Ameliorates Disruption of Hepatic Lipid Metabolism in Farnesoid X Receptor (Fxr)-Null Mice
     Miyata, Masaaki, Sakaida, Yumi, Matsuzawa, Hitomi, Yoshinari, Kouichi, Yamazoe, Yasushi · 2011 · Biological and Pharmaceutical Bulletin
177. α5β1-integrins are sensors for tauroursodeoxycholic acid in hepatocytes
     Gohlke, Holger, Schmitz, Birte, Sommerfeld, Annika, Reinehr, Roland, Häussinger, Dieter · 2013 · Hepatology
178. Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo
     Magdalena Slawa Mroz, Niamh Keating, Joseph B. J. Ward, Rafiquel I. Sarker, Sylvie Amu, Gabriella Aviello, Mark Donowitz, Padraic G. Fallon, Stephen J. Keely · 2013 · Gut
179. Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones
     Michele Pier Luca Guarino, Ping Cong, Michele Cicala, Rossana Alloni, Simone Carotti, José Behar · 2006 · Gut
180. Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB‐756050, in Type 2 Diabetes
     Rebecca J. Hodge, Jiang Lin, Lakshmi S. Vasist Johnson, Elizabeth P. Gould, Gary D. Bowers, Derek J. Nunez, on behalf of the SB‐756050 Project Team · 2013 · Clinical Pharmacology in Drug Development
181. Ligand-dependent Activation of the Farnesoid X-receptor Directs Arginine Methylation of Histone H3 by CARM1
     Meenakshisundaram Ananthanarayanan, SiDe Li, Natarajan Balasubramaniyan, Frederick J. Suchy, Martin J. Walsh · 2004 · Journal of Biological Chemistry
182. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts
     Hicham Id Boufker, Laurence Lagneaux, Hussein Fayyad‐Kazan, Bassam M. Badran, Mehdi Najar, Murielle Wiedig, Ghanem Ghanem, Guy Laurent, Jean‐Jacques Body, Fabrice Journé · 2011 · Bone
183. INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function
     Paolo Comeglio, Ilaria Cellai, Tommaso Mello, Sandra Filippi, Elena Maneschi, Francesca Corcetto, Chiara Corno, Erica Sarchielli, Annamaria Morelli, Elena Rapizzi et al. · 2018 · Journal of Endocrinology
184. In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids
     Sui Peng, Xiaofang Huo, Davood Rezaei, Qiuyang Zhang, Xi Zhang, Chunhua Yu, Kiyotaka Asanuma, Edaire Cheng, Thai H. Pham, David H. Wang et al. · 2014 · American Journal of Physiology-Gastrointestinal and Liver Physiology
185. External biliary drainage and liver regeneration after major hepatectomy
     Ryu Otao, Toru Beppu, Takatoshi Isiko, Kosuke Mima, Hirohisa Okabe, Hiromitsu Hayashi, Toshiro Masuda, A Chikamoto, Hiroshi Takamori, Hideo Baba · 2012 · British journal of surgery
186. INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis
     J. Roth, M. Feigh, S. Veidal, Louise K. D. Fensholdt, Kristoffer T. G. Rigbolt, Henrik H. Hansen, Li Chen, Mathieu Petitjean, W. Friley, N. Vrang et al. · 2018 · World Journal of Gastroenterology
187. Clinical and metabolic effects associated with weight changes and obeticholic acid in non‐alcoholic steatohepatitis
     Bilal Hameed, Norah A. Terrault, Ryan M. Gill, Rohit Seth Loomba, Naga Chalasani, Jay H. Hoofnagle, Mark L. Van Natta, for the NASH CRN · 2018 · Alimentary Pharmacology & Therapeutics
188. Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis
     Caroline Ovadia, Álvaro Perdones-Montero, Konstantina Spagou, Ann Smith, Magali H. Sarafian, María Gómez‐Romero, Elena Bellafante, Louise C.D. Clarke, Fouzia Sadiq, Vanya Nikolova et al. · 2019 · Hepatology
189. Forkhead Box M1 (FoxM1) Gene Is a New STAT3 Transcriptional Factor Target and Is Essential for Proliferation, Survival and DNA Repair of K562 Cell Line
     André Luiz Mencalha, Renata Binato, Gerson Moura Ferreira, Bárbara Du Rocher, Eliana S. F. W. Abdelhay · 2012 · PLoS ONE
190. SUMOylation of the Farnesoid X Receptor (FXR) Regulates the Expression of FXR Target Genes*
     N. Balasubramaniyan, Yuhuan Luo, An-Qiang Sun, F. Suchy · 2013 · Journal of Biological Chemistry
191. TGR 5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure‐induced stress in mice
     Zeena Eblimit, Sundararajah Thevananther, Saul J. Karpen, Heinrich Taegtmeyer, David D. Moore, Luciano Adorini, Daniel J. Penny, Moreshwar S. Desai · 2018 · Cardiovascular Therapeutics
192. Dietary soybean protein ameliorates high-fat diet-induced obesity by modifying the gut microbiota-dependent biotransformation of bile acids
     Keita Watanabe, Miki Igarashi, Xuan Li, Akiho Nakatani, Junki Miyamoto, Yuka Inaba, Asuka Sutou, Tsutomu Saito, Takumi Sato, Nobuhiko Tachibana et al. · 2018 · PLoS ONE
193. TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function
     Grégory Merlen, Nicolas Kahale, José Ursic Bedoya, V. Bidault, H. Simerabet, Isabelle Doignon, Zahra Tanfin, Isabelle Garcin, Noémie Pean, Julien Gautherot et al. · 2019 · Gut
194. Glucose Sensing O-GlcNAcylation Pathway Regulates the Nuclear Bile Acid Receptor Farnesoid X Receptor (FXR)
     Wahiba Berrabah, Pierrette Aumercier, Céline Gheeraert, Hélène Dehondt, Emmanuel Bouchaert, Jérémy Alexandre, Maheul Ploton, Claire Mazuy, Sandrine Caron, Anne Tailleux et al. · 2013 · Hepatology
195. Metagenomic analysis of bile salt biotransformation in the human gut microbiome
     Promi Das, Simonas Marcišauskas, Boyang Ji, Jens Nielsen · 2019 · BMC Genomics
196. Gender-Divergent Profile of Bile Acid Homeostasis during Aging of Mice
     Zidong Donna Fu, Iván L. Csanaky, Curtis D. Klaassen · 2012 · PLoS ONE
197. A dual agonist of farnesoid X receptor (FXR) and the G protein–coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice
     Xiaoxin X. Wang, Yuhuan Luo, Dong Wang, Luciano Adorini, Mark Pruzanski, Evgenia Dobrinskikh, Moshe Levi · 2017 · Journal of Biological Chemistry
198. Bile Acid Induced Morphotype Switch Mediates Intestinal Colonization in Vancomycin Resistant Enterococcus
     Peter T. McKenney, Jinyuan Yan, Julien Vaubourgeix, Simone Becattini, Nina Lampen, Andrew Motzer, Peter J. Larson, Daniel Dannaoui, Sho Fujisawa, João B. Xavier et al. · 2018 · Cell Host & Microbe
199. Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1
     Barbara Renga, Sabrina Cipriani, Adriana Carino, Michele Simonetti, Angela Zampella, Stefano Fiorucci · 2015 · PLoS ONE
200. Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers
     Richard Pencek, Tonya Marmon, Jonathan David Roth, A. Liberman, Roya Hooshmand-Rad, Mark A. Young · 2016 · Diabetes Obesity and Metabolism